Jim Simons acquired 112k NeuroPace shares worth $1.49M. That's 0.00% of their equity portfolio (1987th largest holding). The first NeuroPace trade was made in Q2 2022. Since then Jim Simons bought shares ten more times and sold shares on six occasions. The stake costed the investor $1.2M, netting the investor a gain of 24% so far.